Literature DB >> 33226331

Different positron emission tomography findings in schizophrenia and narcolepsy type 1 in adolescents and young adults: a preliminary study.

Wei-Chih Chin1, Feng-Yuan Liu2,3, Yu-Shu Huang1, Ing-Tsung Hsiao2,3, Chih-Huan Wang4, Ying-Chun Chen1.   

Abstract

STUDY
OBJECTIVES: The association between schizophrenia and narcolepsy has been controversial. We conducted a prospective case control study of schizophrenia and comorbid narcolepsy type 1 in adolescents compared with patients with either diagnosis alone and healthy controls using 18F-fluorodeoxy glucose positron emission tomography, sleep studies, and neurocognitive tests.
METHODS: We included 11 patients (9-20 years old) with schizophrenia and comorbid narcolepsy type 1, 11 with narcolepsy type 1, 11 with schizophrenia, and 11 controls. All groups were matched for age and sex. Participants were required to submit to clinical interviews for sleep and psychiatric disorders, sleep questionnaires, continuous performance test, Wisconsin card sorting test, sleep studies including polysomnography, multiple sleep latency test and actigraphy, and positron emission tomography studies. All data were analyzed to compare the differences between the 4 groups.
RESULTS: The positron emission tomography results demonstrated significant differences in the dual diagnoses group compared with the 3 other groups. Compared with the controls, the dual diagnoses group had a significant presence of hypometabolism in the right mid-frontal, right orbital inferior frontal, and right posterior cingulum and a significant presence of hypermetabolism in the left amygdala, bilateral striatum, bilateral substantia nigra, bilateral basal ganglia, and bilateral thalamus. Continuous performance tests and Wisconsin card sorting tests showed that the dual diagnoses group had the worst performance.
CONCLUSIONS: Patients with schizophrenia and comorbid narcolepsy type 1 had different positron emission tomography findings than those with either schizophrenia or narcolepsy type 1 alone. They also had more neurocognitive impairments and required additional interventions.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  hypersomnia; image studies; multiple sleep latency tests; neurocognitive function; psychosis

Mesh:

Year:  2021        PMID: 33226331      PMCID: PMC8020687          DOI: 10.5664/jcsm.9032

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  37 in total

1.  Validation of a cataplexy questionnaire in 983 sleep-disorders patients.

Authors:  S Anic-Labat; C Guilleminault; H C Kraemer; J Meehan; J Arrigoni; E Mignot
Journal:  Sleep       Date:  1999-02-01       Impact factor: 5.849

Review 2.  Mechanism of action of narcolepsy medications.

Authors:  Chandan R Gowda; Leslie P Lundt
Journal:  CNS Spectr       Date:  2014-11-18       Impact factor: 3.790

3.  Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.

Authors:  M Soyka; W Koch; H J Möller; T Rüther; K Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-18       Impact factor: 5.270

4.  Brain imaging and cognition in young narcoleptic patients.

Authors:  Yu-Shu Huang; Feng-Yuan Liu; Chin-Yang Lin; Ing-Tsung Hsiao; Christian Guilleminault
Journal:  Sleep Med       Date:  2016-01-19       Impact factor: 3.492

5.  Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

Authors:  A Wolkin; J Jaeger; J D Brodie; A P Wolf; J Fowler; J Rotrosen; F Gomez-Mont; R Cancro
Journal:  Am J Psychiatry       Date:  1985-05       Impact factor: 18.112

Review 6.  Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.

Authors:  Rajiv Tandon; Matcheri S Keshavan; Henry A Nasrallah
Journal:  Schizophr Res       Date:  2008-06-02       Impact factor: 4.939

Review 7.  Longitudinal studies of cognition in schizophrenia: meta-analysis.

Authors:  Andrei Szöke; Anca Trandafir; Marie-Estelle Dupont; Alexandre Méary; Franck Schürhoff; Marion Leboyer
Journal:  Br J Psychiatry       Date:  2008-04       Impact factor: 9.319

8.  Prevalence of narcolepsy symptomatology and diagnosis in the European general population.

Authors:  M M Ohayon; R G Priest; J Zulley; S Smirne; T Paiva
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

9.  Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study.

Authors:  R Robert Auger; Scott H Goodman; Michael H Silber; Lois E Krahn; V Shane Pankratz; Nancy L Slocumb
Journal:  Sleep       Date:  2005-06       Impact factor: 5.849

10.  Exploring the presence of narcolepsy in patients with schizophrenia.

Authors:  Gemma Sansa; Alba Gavaldà; Carles Gaig; José Monreal; Guadalupe Ercilla; Roser Casamitjana; Gisela Ribera; Alex Iranzo; Joan Santamaria
Journal:  BMC Psychiatry       Date:  2016-06-01       Impact factor: 3.630

View more
  2 in total

1.  Chronic intermittent hypoxia promoted lung cancer stem cell-like properties via enhancing Bach1 expression.

Authors:  Shengyu Hao; Xiaodan Zhu; Zilong Liu; Xiaodan Wu; Shanqun Li; Pan Jiang; Liyan Jiang
Journal:  Respir Res       Date:  2021-02-17

Review 2.  Pediatric Narcolepsy-A Practical Review.

Authors:  I-Hang Chung; Wei-Chih Chin; Yu-Shu Huang; Chih-Huan Wang
Journal:  Children (Basel)       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.